Caricamento...

Brief Report: Estimating Disease Activity Using Multi‐Biomarker Disease Activity Scores in Rheumatoid Arthritis Patients Treated With Abatacept or Adalimumab

OBJECTIVE: To assess the ability of a multi‐biomarker disease activity (MBDA) test (Vectra DA) to reflect clinical measures of disease activity in patients enrolled in the AMPLE (Abatacept Versus Adalimumab Comparison in Biologic‐Naive RA Subjects with Background Methotrexate) trial. METHODS: In the...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Arthritis Rheumatol
Autori principali: Fleischmann, Roy, Connolly, Sean E., Maldonado, Michael A., Schiff, Michael
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2016
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6099512/
https://ncbi.nlm.nih.gov/pubmed/27111089
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.39714
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !